SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-022813
Filing Date
2020-05-07
Accepted
2020-05-07 16:01:52
Documents
73
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q sbph-10q_20200331.htm 10-Q 1493249
2 EX-10.2 sbph-ex102_98.htm EX-10.2 45850
3 EX-10.3 sbph-ex103_99.htm EX-10.3 20158
4 EX-31.1 sbph-ex311_6.htm EX-31.1 23509
5 EX-31.2 sbph-ex312_8.htm EX-31.2 22989
6 EX-32.1 sbph-ex321_7.htm EX-32.1 16083
  Complete submission text file 0001564590-20-022813.txt   7020471

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT sbph-20200331.xml EX-101.INS 1607110
8 XBRL TAXONOMY EXTENSION SCHEMA sbph-20200331.xsd EX-101.SCH 52300
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sbph-20200331_cal.xml EX-101.CAL 46475
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sbph-20200331_def.xml EX-101.DEF 205993
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE sbph-20200331_lab.xml EX-101.LAB 438712
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sbph-20200331_pre.xml EX-101.PRE 363302
Mailing Address 35 PARKWOOD DRIVE SUITE 210 HOPKINTON MA 01748
Business Address 35 PARKWOOD DRIVE SUITE 210 HOPKINTON MA 01748 508-473-5993 X119
Spring Bank Pharmaceuticals, Inc. (Filer) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37718 | Film No.: 20856180
SIC: 2834 Pharmaceutical Preparations